A review of BF-200 ALA for the photodynamic treatment of mild-to-moderate actinic keratosis.

Abstract

BF-200 ALA is a combination of a nanoscale-lipid vesicle formulation and the prodrug 5-aminolevulinic acid (5-ALA). The nanoemulsion stabilizes the prodrug and enhances its penetration through the stratum corneum. It has shown excellent therapeutic results in both lesion and field-directed photodynamic therapy of actinic keratosis (AK). AK is an early form… (More)
DOI: 10.2217/fon-2017-0247

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.